Breast Cancer 101

A Guide to Breast Cancer by Susan G. Komen

CHAPTER 14

Other Targeted Therapies

CHAPTER 14

Other Targeted Therapies

Chapter Overview

Other Targeted Therapies discusses how drug therapies, including CDK4/6 inhibitors, immunotherapy and PARP inhibitors are used to treat early and locally advanced breast cancers. Side effects of these drugs are also reviewed.

The following topics are discussed in this section:

  • CDK4/6 Inhibitors and Side Effects
    • CDK 4/6 enzymes and inhibitors
    • Abemacicliband ribociclib
    • Indications for abemaciclib and ribociclib
    • Benefits of abemaciclib and ribociclib
    • How abemaciclib and ribociclib are given
    • Common side effects of abemaciclib
    • Possible and rare side effects of abemaciclib
    • Common side effects of ribociclib
    • Possible and rare side effects of ribociclib
  • Immunotherapy and Side Effects
    • How Immunotherapy works
    • Pembrolizumab
    • Indications for pembrolizumab
    • How pembrolizumab is given
    • Possible side effects of pembrolizumab
    • Rare side effects of pembrolizumab
  • PARP Inhibitors and Side Effects
    • PARP enzyme and inhibitors
    • How PARP inhibitors work
    • Olaparib
    • Indication for olaparib
    • How olaparib is given
    • Possible side effects of olaparib